Horváth K - Search Results

1

Anti-inflammatory effect and soft properties of etiprednol dicloacetate (BNP-166), a new, anti-asthmatic steroid.

Kurucz I, Németh K, Mészáros S, Török K, Nagy Z, Zubovics Z, Horváth K, Bodor N. Kurucz I, et al. Among authors: horvath k. Pharmazie. 2004 May;59(5):412-6. Pharmazie. 2004. PMID: 15212312

2

Potency and specificity of the pharmacological action of a new, antiasthmatic, topically administered soft steroid, etiprednol dicloacetate (BNP-166).

Kurucz I, Tóth S, Németh K, Török K, Csillik-Perczel V, Pataki A, Salamon C, Nagy Z, Székely JI, Horváth K, Bodor N. Kurucz I, et al. Among authors: horvath k. J Pharmacol Exp Ther. 2003 Oct;307(1):83-92. doi: 10.1124/jpet.103.053652. Epub 2003 Jul 31. J Pharmacol Exp Ther. 2003. PMID: 12893841

3

Comparative evaluation of Estredox, a brain-targeted estradiol delivery system versus traditional estrogen replacement therapy.

Sziráki I, Horváth K, Bodor N. Sziráki I, et al. Among authors: horvath k. Pharmazie. 2006 Feb;61(2):140-3. Pharmazie. 2006. PMID: 16526562

4

New evidence for the selective, long-lasting central effects of the brain-targeted estradiol, Estredox.

Tapfer MK, Sebestyen L, Kurucz I, Horvath K, Szelenyi I, Bodor N. Tapfer MK, et al. Among authors: horvath k. Pharmacol Biochem Behav. 2004 Mar;77(3):423-9. doi: 10.1016/j.pbb.2003.11.005. Pharmacol Biochem Behav. 2004. PMID: 15006452

5

Anti-inflammatory effects of a cyclosporine receptor-binding compound, D-43787.

Pahl A, Zhang M, Török K, Kuss H, Friedrich U, Magyar Z, Szekely J, Horvath K, Brune K, Szelenyi I. Pahl A, et al. Among authors: horvath k. J Pharmacol Exp Ther. 2002 May;301(2):738-46. doi: 10.1124/jpet.301.2.738. J Pharmacol Exp Ther. 2002. PMID: 11961080

6

Anxiolytic 2,3-benzodiazepines, their specific binding to the basal ganglia.

Horváth EJ, Horváth K, Hámori T, Fekete MI, Sólyom S, Palkovits M. Horváth EJ, et al. Among authors: horvath k. Prog Neurobiol. 2000 Mar;60(4):309-42. doi: 10.1016/s0301-0082(99)00020-9. Prog Neurobiol. 2000. PMID: 10670703 Review.

7

Anxiolytic profile of girisopam and GYKI 52,322 (EGIS 6775). Comparison with chlordiazepoxide and buspirone.

Horváth K, Andrási F, Botka P, Hámori T. Horváth K, et al. Acta Physiol Hung. 1992;79(2):153-61. Acta Physiol Hung. 1992. PMID: 1363928

8

New non competitive AMPA antagonists.

Abrahám G, Sólyom S, Csuzdi E, Berzsenyi P, Ling I, Tarnawa I, Hámori T, Pallagi I, Horváth K, Andrási F, Kapus G, Hársing LG Jr, Király I, Patthy M, Horváth G. Abrahám G, et al. Among authors: horvath k, horvath g. Bioorg Med Chem. 2000 Aug;8(8):2127-43. doi: 10.1016/s0968-0896(00)00133-4. Bioorg Med Chem. 2000. PMID: 11003158

9

Neuropharmacology of a new psychotropic 2,3-benzodiazepine.

Andrási F, Horváth K, Sineger E, Berzsenyi P, Borsy J, Kenessey A, Tarr M, Láng T, Kórösi J, Hámori T. Andrási F, et al. Among authors: horvath k. Arzneimittelforschung. 1987 Oct;37(10):1119-24. Arzneimittelforschung. 1987. PMID: 2893623

10

A new psychoactive 5H-2,3-benzodiazepine with a unique spectrum of activity.

Horváth K, Andrási F, Berzsenyi P, Pátfalusi M, Patthy M, Szabó G, Sebestyén L, Bagdy E, Körösi J, Botka P, et al. Horváth K, et al. Arzneimittelforschung. 1989 Aug;39(8):894-9. Arzneimittelforschung. 1989. PMID: 2573361

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,020 results

Search Page

Filters